Medcura CMO, Dr. Ken Renkens Interviewed by Orthopedics This Week

Medcura’s Chief Medical Officer, Kenneth Renkens, M.D., recently connected with Orthopedics This Week to discuss the formation of the Medcura, Inc.’s Spinal Surgery Advisory Board to support the development and launch of LifeGel™ Absorbable Hemostatic Gel.

Read the article from Orthopedics This Week.

Learn more about the advisory board in this press release.

‍

Disclaimer:

LifeGel™ and its application tips are currently in development. All intended uses and/or indications for use for this medical device and its application tips have not been cleared or approved by the FDA.